A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)
Clinical trial NCT06917742 · RECRUITING
Trial details
- NCT number
- NCT06917742
- Sponsor
- Capstan Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-09
- Primary completion
- 2027-11-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.